Venanzio Vella
Senior Epidemiology Lead @GSK
Signup · Get unlimited contacts
WORK HISTORY
Senior Epidemiology Lead @GSK
Key Epidemiologist for Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Shigella sonnei.\\\\n- Author of the epidemiology section of Briefing Documents for pre-IND consultation with FDA for first time in human clinical trials\\\\n- Coordinator of retrospective database studies in US and EU hospitals to estimate the incidence of Staphylococcus aureus in skin and soft tissue infections, and in hip and knee prosthetic infections.\\\\n- Epidemiologist of a task force to identify target pathogens and target groups for monoclonal antibodies.\\\\n- Interpretation of safety signals in clinical trials and post-marketing surveillance.\\\\n- EFPIA Leader of PRIMAVERA an Innovative Medicine Initiative (IMI) supported project, to develop mathematical models to predict the impact of vaccines and Monoclonal Antibodies on Antimicrobial Resistamce in Europe member of the COMBACTE Network to fight antimicrobial resistance \\\\n\\\\n \\\\n \\\\n\\\\n \\\\n
EDUCATION
Sapienza Università di Roma
Specialty, Paediatrics
Sapienza Università di Roma
MD, medicine
University of York
MSc, Health Economics
London School of Hygiene and Tropical Medicine, U. of London
MSc, Epidemiology
London School of Hygiene and Tropical Medicine, U. of London
Doctor of Philosophy - PhD, Epidemiology
SKILLS
ABOUT VENANZIO VELLA
A comprehensive background in epidemiology and health economics with a wide exposure to…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.